Top 50 Life Science Startup Investors in France (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Bpifrance
VC Fund
|
28 | France, United States, Switzerland | Seed, Venture - Series Unknown, Series A | Software, Health Care, Biotechnology | $752k–$34M |
|
Kurma Partners
VC Fund
|
9 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Pharmaceutical | $2.8M–$98M |
|
Seventure Partners
VC Fund
|
7 | France, United States, Germany | Series A, Series B, Seed | Biotechnology, Software, Health Care | $1.1M–$63M |
|
Idinvest Partners
VC Fund
|
7 | France, United States, Germany | Series A, Series B, Venture - Series Unknown | Software, Health Care, Biotechnology | $3.4M–$66M |
|
Omnes Capital
VC Fund
|
6 | France, Germany, United States | Series A, Series B, Venture - Series Unknown | Biotechnology, Software, Health Care | $3.8M–$53M |
|
Elaia
VC Fund
|
5 | France, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.1M–$50M |
|
Eurazeo
VC Fund
|
5 | France, United States, United Kingdom | Venture - Series Unknown, Seed, Series B | Software, Information Technology, Health Care | $3.2M–$156M |
|
Sofinnova Partners
VC Fund
|
5 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
Angels Santé
VC Fund
|
4 | France, India, United States | Seed, Venture - Series Unknown, Angel | Health Care, Biotechnology, Medical Device | $664k–$8.2M |
|
Paca Investissement
VC Fund
|
4 | France | Seed, Venture - Series Unknown | Software, Internet, Manufacturing | $325k–$5.2M |
|
AdBio partners
VC Fund
|
4 | France, Spain, Belgium | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Pharmaceutical | $2.2M–$37M |
|
Blue Horizon Corporation
VC Fund
|
3 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $450k–$40M |
|
Galia Gestion
VC Fund
|
3 | France, United States | Venture - Series Unknown, Series A | Software, Manufacturing, Biotechnology | $849k–$11M |
|
Beyond Impact
VC Fund
|
3 | United States, France, United Kingdom | Seed, Series A, Venture - Series Unknown | Food and Beverage, Food Processing, Biotechnology | $670k–$14M |
|
Advent Life Sciences
VC Fund
|
3 | United States, United Kingdom, France | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Medical | $5.5M–$104M |
|
XAnge
VC Fund
|
3 | France, Germany, Belgium | Seed, Series A, Series B | Software, SaaS, Health Care | $1.1M–$75M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
Karista
VC Fund
|
3 | France, United States, Finland | Seed, Series A, Series B | Software, Biotechnology, Health Care | $768k–$33M |
|
Entrepreneurs First
VC Fund
|
3 | United Kingdom, Singapore, United States | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Machine Learning | $54k–$41M |
|
Social Starts
VC Fund
|
3 | United States, Canada, Germany | Seed, Series A, Venture - Series Unknown | Software, Health Care, Artificial Intelligence | $50k–$14M |
|
Polytechnique Ventures
VC Fund
|
2 | France, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Robotics, Information Technology | $1.3M–$17M |
|
Invus
VC Fund
|
2 | United States, France, United Kingdom | Series B, Series C, Series A | Biotechnology, Health Care, Therapeutics | $14M–$230M |
|
Partech
VC Fund
|
2 | France, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, E-Commerce | $1M–$56M |
|
Sofimac Investment Managers
VC Fund
|
2 | France, Italy, Austria | Venture - Series Unknown, Seed | Health Care, Biotechnology, Manufacturing | $268k–$8.7M |
|
Lundbeckfonden Ventures
VC Fund
|
2 | United States, Denmark, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $10M–$95M |
|
JDRF T1D Fund
VC Fund
|
2 | United States, Canada, France | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Medical | $7M–$130M |
|
Air Street Capital
VC Fund
|
2 | United States, United Kingdom, France | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Biotechnology | $1.1M–$48M |
|
InnoBio Fund
VC Fund
|
2 | France, United States | Series A, Series B, Series C | Biotechnology, Therapeutics, Pharmaceutical | $14M–$26M |
|
Sylvain Zimmer
Angel
|
2 | France, United States, United Kingdom | Seed, Pre-Seed, Angel | Software, SaaS, Real Estate | $118k–$10M |
|
Mtec Holding Gmbh
VC Fund
|
2 | France | Seed, Series A | Computer, Health Care, Life Science | |
|
AQUITI Gestion
VC Fund
|
2 | France, United States | Venture - Series Unknown, Seed, Series A | Software, Biotechnology, Manufacturing | $531k–$18M |
|
Alexandria Venture Investments
VC Fund
|
2 | United States, Canada, France | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2M–$150M |
|
Heartcore Capital
VC Fund
|
2 | United States, Denmark, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, E-Commerce | $1.2M–$58M |
|
Horizons Ventures
VC Fund
|
2 | United States, United Kingdom, Canada | Series A, Series B, Seed | Artificial Intelligence, Software, Biotechnology | $1M–$110M |
|
WiSEED
VC Fund
|
2 | France, Norway | Seed, Venture - Series Unknown, Series A | Software, Biotechnology, Manufacturing | $392k–$7.8M |
|
Bertrand Jacquelot
Angel
|
2 | France, United States | Pre-Seed, Seed, Angel | Food and Beverage, E-Commerce, Information Technology | $120k–$7.8M |
|
Beurer
VC Fund
|
2 | Germany, France, Estonia | Seed, Series A, Pre-Seed | Health Care, Medical, Software | $1.2M–$10M |
|
Andrew Nutter
Angel
|
2 | France, United Kingdom, United States | Seed, Pre-Seed, Venture - Series Unknown | Software, SaaS, FinTech | $550k–$4.9M |
|
European Commission
VC Fund
|
2 | France, Spain, Germany | Grant, Seed, Pre-Seed | Software, Biotechnology, Artificial Intelligence | $55k–$51M |
|
Bernard Majoie
Angel
|
2 | France, Belgium | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Care | $1.4M–$2.7M |
|
Kinled Holding
VC Fund
|
2 | United Kingdom, United States, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | $594k–$40M |
|
IRDI SORIDEC Gestion
VC Fund
|
2 | France, Brazil, Singapore | Seed, Series A, Venture - Series Unknown | Software, Biotechnology, Medical | $1.3M–$13M |
|
Thia Ventures
VC Fund
|
2 | United States, France, Denmark | Series A, Seed, Pre-Seed | Biotechnology, Health Care, Manufacturing | $3.4M–$48M |
|
Wendel Growth
VC Fund
|
2 | France, Luxembourg | Series A, Venture - Series Unknown | Analytics, Open Source, Biotechnology | $16M–$38M |
|
Eutopia VC
VC Fund
|
2 | France, Belgium, Denmark | Seed, Series A, Venture - Series Unknown | E-Commerce, Retail, Food and Beverage | $1.3M–$48M |
|
Point Nine
VC Fund
|
2 | Germany, United States, France | Seed, Series A, Series B | Software, SaaS, Artificial Intelligence | $900k–$62M |
|
Siparex Groupe
VC Fund
|
2 | France, United States, Italy | Private Equity, Series A | Manufacturing, Software, Information Technology | $1.5M–$27M |
|
Societe Generale Asset Management
VC Fund
|
1 | France, United States, Germany | Series B, Series A | Biotechnology, Software, Health Care | |
|
Meusinvest (Noshaq)
VC Fund
|
1 | Belgium, France, Germany | Series A, Seed | Biotechnology, Health Care, Medical | |
|
Banque Populaire Group
VC Fund
|
1 | France | Seed, Pre-Seed | Manufacturing, Energy, Software | |
| Access all 337 investors in France Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 1710
- Round size: Seed $752k–$6.1M; Series A $2.6M–$34M; Venture - Series Unknown $1.1M–$31M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fresh fund, raised $27M in 2025
Portfolio highlights
- Cube — Cube is a French accelerator for tech startups, particularly in Web3, blockchain, and innovation, rebranded from Cube3. It provides a 9-month program combining strategic mentoring, customized funding, media production, and investor networking to scale promising ventures.
- Ostrea — OSTREA is a pioneering company in the creation of high-performance materials based on bio-minerals: seashells.
- NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 145
- Round size: Seed $2.8M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $236M in 2024
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B, Seed
- Geography: France, United States, Germany
Investor stats
- Total investments: 274
- Round size: Seed $1.1M–$4.7M; Series A $3.2M–$28M; Series B $3.4M–$63M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Ekstere — Ekstere facilitates selling and purchasing verified-quality used bicycles at a reasonable price.
- Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
- Presto Engineering — We enable companies imagine and implement microelectronics solutions in high-value markets such as Industrial, Automotive, Communication and Medical.
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: France, United States, Germany
Investor stats
- Total investments: 350
- Round size: Series A $3.4M–$22M; Series B $7.8M–$66M; Venture - Series Unknown $4.1M–$37M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $97M in 2021
Portfolio highlights
- Actility — Actility provides IoT connectivity and solutions to power smart cities and industries.
- Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
- StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Omnes Capital takes a unique approach to renewable energy, transforming developers into independent power producers to provide green energy to millions.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: France, Germany, United States
Investor stats
- Total investments: 186
- Round size: Series A $4.3M–$41M; Series B $4.4M–$53M; Venture - Series Unknown $3.8M–$46M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely actively investing — fresh fund, raised $132M in 2025
Portfolio highlights
- Adictiz — Adictiz, a French company founded in 2009 by Charles Christory, develops and publishes social games for the web and mobile phones.With successful brands including “Space Dog” and “What a Stupid Pigeon”, which attract close to 2.5 million players every month, Adictiz has established itself as an expert player in social and mobile gaming.Basedat the EuraTechnologies economic excellence hub in Lille, which is dedicated to serving information and communication technology companies, Adictiz set up Adictiz Studio in late 2011, which specialises in the creation of customised social games for brands. Adictiz Studio was recently selected by Facebook as a PMD (Preferred Marketing Developer).
- Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
- EnduroSat — Enabling profitable LEO satellite constellations with standardized satellites and fixed-cost space service. 100+ satellites deployed to orbit
Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: France, United States, Spain
Investor stats
- Total investments: 241
- Round size: Seed $1.1M–$7.6M; Series A $2.7M–$23M; Series B $4.2M–$50M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fresh fund, raised $154M in 2026
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- RelaiSanté — RelaiSanté provides a digital platform that connects hospitals and home care providers to coordinate patient return home.
- Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
Eurazeo is a private equity and venture capital firm that invests in SMEs and manages a diversified portfolio of assets.With its expertise in private equity, real estate, and private debt, the group supports companies of all sizes in their development commitment through the commitment of its 235 professionals. It provides companies with thenecessary investments needed to realize their growth potential.The firm was founded in 1969 and is based in Paris, Ile-de-France, France.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Seed, Series B
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 384
- Round size: Seed $3.2M–$16M; Series B $17M–$125M; Venture - Series Unknown $7.8M–$156M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely actively investing — fresh fund, raised $2.6B in 2026
Portfolio highlights
- Excelya — Excelya is an R&D company that specializes in consulting, clinical trials, therapeutic research, data management, and medical writing.
- Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
- Celcius Logistics Solutions — India's Largest 'ONLINE " cold chain network.Book reefer vehicles, Cold Storages or get booking for your vehicle and cold storages across India instantly with the best price
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 353
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
- EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Venture - Series Unknown, Angel
- Geography: France, India, United States
Investor stats
- Total investments: 37
- Round size: Seed $1.1M–$4.6M; Angel $687k–$1.3M; Venture - Series Unknown $664k–$8.2M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
- StemInov — StemInov is developing a stem cell therapy for inflammatory diseases with a first focus on critical care: septic shock and ARDS
- SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.
Show more...Investment focus
- Industry: Software, Internet, Manufacturing
- Stage:Seed, Venture - Series Unknown
- Geography: France
Investor stats
- Total investments: 73
- Round size: Seed $325k–$1.7M; Venture - Series Unknown $1.1M–$5.2M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
- SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
- C4Diagnostics — Dana69 adalah tempat penyedia link login game online yang bisa di mainkan dengan menggunakan smartphone android dan iphone dan bisa melakukan top up slot dana 10k atau slot deposit dana 10k selalu online 24 jam.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, Spain, Belgium
Investor stats
- Total investments: 32
- Round size: Seed $2.2M–$18M; Series A $18M–$37M; Venture - Series Unknown $2.2M–$16M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $116M in 2021
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 109
- Round size: Seed $2M–$10M; Pre-Seed $450k–$6.3M; Series A $2M–$40M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $222M in 2021
Portfolio highlights
- WOW EARN — Discover WOW EARN, the all-in-one Web3 app with crypto mining, multi-chain wallet, staking NFTs, and marketplace dApps. Join the global Web3 community today.
- EV Biotech — DANU strain engineering creates Precision Biopolymers For High-Performance Applications through strain engineering and AI.
- foodforecast — AI supported solution to reduce food waste.
Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.
Show more...Investment focus
- Industry: Software, Manufacturing, Biotechnology
- Stage:Venture - Series Unknown, Series A
- Geography: France, United States
Investor stats
- Total investments: 55
- Round size: Series A $849k–$7.2M; Venture - Series Unknown $1.3M–$11M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $26M in 2013
Portfolio highlights
- Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
- Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
- Mon Chasseur Immo — Mon Chasseur Immo is a Real Estate, based in Languedoc Roussillon.
Beyond Impact Advisors is created to facilitate investment in products and services that are either inherently vegan in nature or are cruelty-free and remove mankind’s reliance on the raising of animals for slaughter.Beyond Impact’s core investment thesis centers on sustainability as a pillar of risk management and economic valuation. Due to theheavy environmental impact, the use of animals is inherently unsustainable and alternatives need to be found and funded. Coinciding with this we are seeing an accelerating societal shift in favour of vegan, cruelty-free and plant-based alternatives, based on the environmental imperative, health concerns and compassion for animals.As such, Beyond Impact targets significantly impactful companies which have positioned their products and services to meet this growing demand, favouring those with clear technological advantages and whose products outstrip the qualities of the animal-derived material they replace.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 41
- Round size: Seed $670k–$7M; Series A $2.9M–$14M; Venture - Series Unknown $2.1M–$2.3M
- Lead/follow: 12% lead, 88% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Jay&Joy — Jay&Joy is the first plant-based creamery in France engaged in manufacturing alternatives to cheese made from almond milk and cashew nuts.
- Paleo — Paleo creates animal-free and GMO-free ingredients for plant-based meat and fish alternatives. They enhance taste, aroma, color and nutritional value.
- Perfat Technologies — Perfect fats for better foods.
Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 73
- Round size: Series A $5.5M–$51M; Series B $21M–$97M; Venture - Series Unknown $7M–$104M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
- Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, Germany, Belgium
Investor stats
- Total investments: 240
- Round size: Seed $1.1M–$8M; Series A $3M–$22M; Series B $6M–$75M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $261M in 2021
Portfolio highlights
- ELDIM — Eldim proposes photometric and calorimetric products of instrumentation allowing to qualify the ergonomic parameters and the quality of the image of the flat screens. Its customers (manufacturers of components or sreen-Sharp, Sony, Samsung, -or integrators-IBM, Apple, Valeo, Honeywell, Nokia, Motorola-) are mainly foreigns.
- Skello — Skello is the The AI HR solution for frontline teams. HR tools were designed for offices, yet 55% of the workforce works on their feet and deserves technology designed for the field. Our mission is to improve their daily lives. For managers and HR directors, Skello offers seamless management from hiring to the payslip: our AI automatestime-consuming tasks so they can anticipate and supervise while maintaining full control. For teams, Skello guarantees a transparent and collaborative experience from their very first day. In July 2026, we reached a major milestone with the announcement of €200 million in funding to accelerate our development. After 10 years spent listening to our customers, this new chapter solidifies our conviction: technology must assist and facilitate work, without ever replacing humans. Our ambition is to be the go-to AI HR management solution for all frontline teams in Europe.
- Intent Technologies — Intent Technologies provides a dedicated service platform for real estate players that allows them to optimize the operation of a heritage and build and distribute their services. The platform integrates a growing connected ecosystem including real estate managers (social and private landlords, trustee, real estate, communities, etc.), serviceproviders (facility management, energy, elevators, personal services, insurance, etc.), publishers business software (BIM, ERP, CRM, CMMS, BI, etc.) and IoT solution providers.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 108
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, United States, Finland
Investor stats
- Total investments: 161
- Round size: Seed $768k–$6.2M; Series A $1.4M–$23M; Series B $2.5M–$33M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — raised $44M in 2021
Portfolio highlights
- Kynogon — Autodesk game middleware products, including Beast, Navigation, HumanIK and Scaleform, will no longer be available for purchase.
- Voluntis — Voluntis design digital therapeutics to people across multiple areas to self-manage their treatment improving real-world outcomes.
- DBV Technologies — DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively.
We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Singapore, United States
Investor stats
- Total investments: 485
- Round size: Seed $54k–$6.7M; Pre-Seed $55k–$2.7M; Series A $5.1M–$41M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely actively investing — fresh fund, raised $133M in 2026
Portfolio highlights
- ByteAsk — Derisk your AI agents
- Sourcepulse — Your early warning system for software delivery (YC S23)
- Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 444
- Round size: Seed $50k–$3.6M; Series A $3.1M–$14M; Venture - Series Unknown $626k–$6.1M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $8.9M in 2022
Portfolio highlights
- Mae Health — Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.
- Ruby Bio — Ruby Bio is a biosynthesis platform that can manufacture complex molecules that are biodegradable and non-toxic. Ruby Bio uses naturally occurring yeast as a factory to convert low-cost sugar into high-value products.
- Funnel — Our revolutionary CRM property management software saves both time and money for agents and owners while making leasing more efficient.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Polytechnique Ventures support entrepreneurs from the School's ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Robotics, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: France, United Kingdom, Germany
Investor stats
- Total investments: 26
- Round size: Seed $2M–$11M; Pre-Seed $1.3M–$2.7M; Series A $6.5M–$17M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $39M in 2023
Portfolio highlights
- Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
- Goodvest — Goodvest is an investment app (life insurance) that builds a better world, in line with your values and promoting performance.
- Jimmy — Jimmy develops and operates thermal generators that supply industrial facilities with process heat produced through nuclear fission. The company designs compact generators that use high-temperature reactor technology to create heat without combustion and deliver it to industrial systems through heat transfer circuits. Its systems connect to factoryinfrastructure and provide heat for processes such as steam production, thermal oil heating, or hot air generation. Jimmy installs, operates, and manages these generators as integrated energy units adapted to the heat demand of each industrial site. The technology relies on micro-reactor architecture and modular deployment so multiple units can be combined to match required thermal output. Through this approach, Jimmy provides industrial heat that replaces fossil-fuel-based heat sources in manufacturing and processing operations.
Invus recognizes that every company is unique and that extraordinary business performance cannot be achieved by following a formulaic approach. Due to their unique structure, they have a great deal of flexibility in the types of companies and situations where they can get involved.They know that real transformation takes time and that it is nevera straight line. They fully align their incentives with their partners and have the wherewithal and long-term commitment to see through any bumps along the way.They have been successfully empowering owner-managers since 1985. They have been reinvesting the same pool of money from the same group of European families (through their Artal investment vehicle) since their founding. Today they manage over $4 billion in an evergreen fund and work out of offices in New York, London, Paris and Hong Kong.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series C, Series A
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 302
- Round size: Series A $14M–$200M; Series B $35M–$230M; Series C $31M–$165M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $210M in 2021
Portfolio highlights
- Aive — Turn 1 master into unlimited, brand-controlled versions. Automate post-production, scale your output, and take back control of video performance.
- Gossamer Bio — Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focuson areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
- Zero Motorcycles — Manufacturer of 100% electric motorcycles for the street and dirt
Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Series B
- Geography: France, United States, Germany
Investor stats
- Total investments: 694
- Round size: Seed $1M–$8.8M; Series A $4.5M–$28M; Series B $9M–$56M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fresh fund, raised $345M in 2026
Portfolio highlights
- Modeinspect — acreom is the integrated markdown knowledge base with tasks. Your personal daily driver for your dev workflow.
- TeamToolz — TeamToolz creates and implements user-friendly applications that simplify and streamline the creation, management and archiving of marketing communications. Addressing the urgency of time to market, our web-based tools better enable entire brand launches by coordinating the workflow of multiple outside agencies and internal groups, for moreintegrated worldwide brand management.
- Revibe — Buy refurbished & used electronics (Smartphones, Laptops) in UAE at Revibe. Free delivery & 12 months warranty. Certified tech by our experts. Order Now!
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Venture - Series Unknown, Seed
- Geography: France, Italy, Austria
Investor stats
- Total investments: 74
- Round size: Seed $268k–$3.1M; Venture - Series Unknown $556k–$8.7M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
- Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
- Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 72
- Round size: Series A $10M–$50M; Series B $20M–$95M; Series C $10M–$53M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- SNIPR Biome — We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
- Women in Life Science Denmark — WiLD is a networking platform for women in senior positions in business and academia that is motivating and focused on science.
The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: United States, Canada, France
Investor stats
- Total investments: 56
- Round size: Series A $7M–$105M; Series B $18M–$130M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Zag Bio — Zag Bio is harnessing the immune system in a whole new way by targeting the thymus to change treatment possibilities for millions of patients with autoimmune diseases.
- Tetragenetics — Our protein production platform provides recombinant transmembane proteins, including ion channels and GPCRs, for antibody drug discovery
- vTv Therapeutics — vTv Therapeutics, a pharmaceutical company, focuses on the discovery and development of human therapeutics to fill unmet medical needs. Its mission is to utilize its innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines.vTv Therapeutics has a pipeline of small molecule clinicaland pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, metabolic disorders, inflammation, and cancer. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The quality and breadth of vTv's product candidate pipeline, platform technology, scientific team, and strategic collaborations have enabled it to become a fully integrated pharmaceutical company.The company's commitment to drug discovery is reflected in its medical solutions and the many exciting potential new treatment options in its pipeline. The company's major R&D activities have focused on central nervous system disorders, metabolic disorders, inflammation and oncology.vTv Therapeutics is advancing several proprietary drug candidates. The company's lead candidate, azeliragon (aka TTP488), is a novel, orally bioavailable small molecule compound that is being developed for the treatment of Alzheimer's disease. In Phase 2 clinical trial in patients with mild to moderate Alzheimer's disease, azeliragon showed a statistically significant difference of more than 3 points in ADAS-cog at 18 months compared to placebo.Azeliragon has been granted Fast Track Designation and agreement on its Phase 3 protocol has been reached with FDA via a Special Protocol Assessment (SPA). The Phase 3 study in patients with mild Alzheimer's disease was initiated in April 2015 with a clear path forward to registration with the aim to demonstrate disease modification.vTv Therapeutics is also prosecuting the clinical development of TTP399, a novel functionally liver-selective Glucokinase Activator ("GKA") for the treatment of type 2 diabetes. In a Phase 2a study, TTP399 normalized patients' HbA1c without inducing hypoglycemia, after only six weeks of treatment. A six-month Phase 2 study is ongoing.
Air Street Capital provides venture capital funding and strategic support focused on early-stage companies that develop products based on artificial intelligence. It invests primarily at pre-seed, seed, and Series A stages in firms working on AI-first technology, software infrastructure, machine-learning tools, and AI-enabled life scienceapplications. The firm pairs capital investment with advisory input on product, market, and technology strategy, and facilitates connections to its broader network of AI and technology stakeholders. Air Street Capital also shares industry insights through publications and community initiatives aimed at supporting AI and related tech ecosystems.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 49
- Round size: Seed $1.8M–$14M; Pre-Seed $1.1M–$14M; Series A $14M–$48M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fresh fund, raised $232M in 2026
Portfolio highlights
- Jack & Jill AI — Jack helps candidates find the perfect job and Jill helps companies find the perfect candidate.
- Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
- Macrodata Labs — Turn Physical AI data into training signal: 3D hand tracking, automated QA, and action labeling at scale for robot and egocentric datasets.
InnoBio is a French venture capital fund of €140 million, managed by CDC Enterprises (www.cdcentreprises.fr) and for 37 per cent subscribed by the FSI and leading international pharmaceutical companies in France. The fund makes direct equity and quasi-equity investments in companies that provide innovative technological products and services in thehealthcare market.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: France, United States
Investor stats
- Total investments: 14
- Round size: Series A $16M–$21M; Series B $14M–$21M; Series C $18M–$26M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Millendo Therapeutics — Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.
- Diotheris — Diotheris develops bacterial therapies of the human skin and mucosal microbiome intended to protect against pathogenic bacteria. The company's products are based on live bacteria includes NASOFLORE which targets Staphylococcus aureus, enabling the prevention of infections due to major pathogen and protecting patients against biologicalthreats.
- AlgoTherapeutix — AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
Sylvain Zimmer is based out of Paris, Ile-de-France and is the Chief Technology Officer of La Suite territoriale (EIG) of Direction interministérielle du numérique. Sylvain previously worked at Contentsquare as a head of the CTO office. Sylvain Zimmer attended the National School of Computer Science and Applied Mathematics of Grenoble.
Show more...Investment focus
- Industry: Software, SaaS, Real Estate
- Stage:Seed, Pre-Seed, Angel
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 27
- Round size: Seed $740k–$10M; Angel $400k–$500k; Pre-Seed $118k–$2.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
- Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
- TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Holding Company
Show more...Investment focus
- Industry: Computer, Health Care, Life Science
- Stage:Seed, Series A
- Geography: France
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- PKVitality — PKvitality is an advanced bio-wearable company. Fusing 20 years of expertise in consumer electronics with 20 years of biological research, PKvitality brings its patented SKinTaste technology to market. SKinTaste is a revolutionary biosensor array that uses micro-needles (<1mm long) to collect and analyze chemical compositions of the interstitialfluid found just below the surface of the skin. Using this technology, PKvitality is developing K'Watch, a continuous glucose monitor in the form of a smartwatch to change the lives of millions of diabetics.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 60
- Round size: Seed $531k–$6.5M; Series A $849k–$18M; Venture - Series Unknown $1.2M–$12M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — raised $7.9M in 2010
Portfolio highlights
- Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
- RelaiSanté — RelaiSanté provides a digital platform that connects hospitals and home care providers to coordinate patient return home.
- CardNexus — CardNexus provides a digital platform for managing, trading, and selling trading card collections.
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 297
- Round size: Seed $2M–$30M; Series A $12M–$100M; Series B $25M–$150M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Leal Therapeutics — Leal Therapeutics develops novel therapeutics for patients.
- Vedana Therapeutics — Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
- Khartis Therapeutics — Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. The company focuses on discovering and developing drug candidates intended to address chronic conditions and immune-mediated diseases.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Series B
- Geography: United States, Denmark, Germany
Investor stats
- Total investments: 217
- Round size: Seed $1.2M–$11M; Series A $3.4M–$27M; Series B $9.5M–$58M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $179M in 2024
Portfolio highlights
- Davis AI — Davis AI provides AI-driven real estate development services focused on early-stage feasibility studies and architectural design. The company combines proprietary generative models, including its Gaudi-1 architectural generation model, with in-house architects to deliver site analysis, regulatory diagnostics, volumetrics, financial modeling, andinvestment analysis. Davis AI also produces architectural outputs such as floor plans, unit mix optimization, and space planning. Its workflow ingests client data rooms and enriches them with regulatory, market, and site data, turning these into constraints that guide every result. Outputs are refined and validated by human experts before delivery and are intended for real estate developers, investors, and other project stakeholders.
- Fora — Fora's expert travel advisors will help you plan your dream trip while unlocking exclusive perks and upgrades. Welcome to the modern travel agency.
- PhaseTree — Materials design simulation company - PhaseTree ApS
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 344
- Round size: Seed $1M–$10M; Series A $5.8M–$42M; Series B $10M–$110M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Magisto — Magisto online video editor is a fast & powerful video maker. Turn your photos and video clips into video stories with Magisto movie editor. Start free!
- Jobspotting — Jobspotting is a recommendations engine that suggests relevant jobs to users based on their skills and experience. The engine is powered by Skills Graph and Semantic Analysis technology. The company was founded in 2013 in Berlin, Germany by ex-Googlers Hessam Lavi, Jan Backes and Manuel Holtz. Robin Haak joined the founding team in 2014 aftermeeting them through the Axel Springer Plug and Play Accelerator Programme, of which he was a co-founder. Jobspotting successfully acquired seed funding.
- Atomo Coffee — Atomo Coffee is a developer of molecular coffee. Atomo has reverse-engineered the coffee bean to create a smooth cup of coffee, made of naturally derived ingredients, and more sustainable than current commercial coffee.
Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, Norway
Investor stats
- Total investments: 34
- Round size: Seed $392k–$3.3M; Series A $1.3M–$7.8M; Venture - Series Unknown $1M–$6.5M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
- BiPER Therapeutics — BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.
Show more...Investment focus
- Industry: Food and Beverage, E-Commerce, Information Technology
- Stage:Pre-Seed, Seed, Angel
- Geography: France, United States
Investor stats
- Total investments: 20
- Round size: Seed $1.5M–$7.8M; Pre-Seed $120k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
- Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
- Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
We offer a range of more than 500 products, and ever since 1919 we have been delivering what our claim promises: health and wellness. Our product ranges will ensure you feel great all-round! From medical products specialized in prevention and diagnosis, to weight and diagnosis products, as well as therapy devices an
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, France, Estonia
Investor stats
- Total investments: 6
- Round size: Seed $1.2M–$2.5M; Series A $6.8M–$10M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- PKVitality — PKvitality is an advanced bio-wearable company. Fusing 20 years of expertise in consumer electronics with 20 years of biological research, PKvitality brings its patented SKinTaste technology to market. SKinTaste is a revolutionary biosensor array that uses micro-needles (<1mm long) to collect and analyze chemical compositions of the interstitialfluid found just below the surface of the skin. Using this technology, PKvitality is developing K'Watch, a continuous glucose monitor in the form of a smartwatch to change the lives of millions of diabetics.
- Healthy Networks — Healthy Networks flagship product, LungPass, is a smart stethoscope for lungs. It distinguishes serious and mild respiratory conditions by analysing lung sounds & symptoms. Easy to use, precise and affordable, LungPass is poised to become a go-to solution for people to own their respiratory health and for healthcare providers to expand theirservice coverage.
- microsynetics GmbH — Developing hardware and software to help elderly people gaining more freedom and quality of life. Our first product is an emergency wristband which works together with an app, also connecting relatives via smartphone and phone integrated in the emergency wristband. The automated AI-based fall detection guarantees help even when the user - afteraccident - isn't capable anymore of activating the emergency call via integrated button.
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: France, United Kingdom, United States
Investor stats
- Total investments: 26
- Round size: Seed $550k–$4.9M; Pre-Seed $902k–$3.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Yavin — Yavin provides modern point-of-sale solutions for European merchants. Yavin is a tool to receive payments, sell smarter, and grow the business.
- Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
- EV Biotech — DANU strain engineering creates Precision Biopolymers For High-Performance Applications through strain engineering and AI.
The official website of the European Commission, providing access to information about its political priorities, policies and services
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Grant, Seed, Pre-Seed
- Geography: France, Spain, Germany
Investor stats
- Total investments: 307
- Round size: Seed $117k–$10M; Grant $117k–$51M; Pre-Seed $55k–$5.4M
- Lead/follow: 68% lead, 32% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Olenbee — Olenbee develops fintech solutions that connect employee benefits directly to everyday card spending. The company offers a mobile application and employer platform that link meal vouchers, gift vouchers and other planned benefits to employees’ usual bank cards and accounts. Its title-restaurant product Olenfood allows food-related expenses to beidentified from card transactions and reimbursed in line with regulation. The Olengift service applies the same principle to gift vouchers without dedicated cards or closed merchant networks. Olenbee also works on additional benefit lines such as culture, sustainable mobility, sport, holidays and home office support. Its infrastructure is designed to handle eligibility rules and integrate with HR and payroll processes for employers, while providing dedicated spaces for merchants and employees.
- VaxThera — VaxThera develops and produces vaccines to prevents and treats diseases.
- Sanofi Germany — Sanofi is a life sciences company specialising in the development, manufacture, and marketing of innovative therapeutic solutions.
Bernard Majoie - President @ Fournier-Majoie
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: France, Belgium
Investor stats
- Total investments: 6
- Round size: Seed $1.4M–$2.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 144
- Round size: Seed $594k–$14M; Series A $1.7M–$40M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
- Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
- Cornea Sense — CorneaSense is a medtech startup developing a non-invasive, eye-based sensing device that measures ocular surface hydration to enable early detection and monitoring of conditions such as dry eye disease and systemic health disorders. The technology aims to provide real-time, objective eye biomarkers for improved clinical diagnosis and patient care.
IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, Brazil, Singapore
Investor stats
- Total investments: 54
- Round size: Seed $1.7M–$5.8M; Series A $3.7M–$13M; Venture - Series Unknown $1.3M–$12M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Donecle — Automated aircraft inspections by drone for airlines and MRO. Donecle makes aircraft maintenance faster, safer and more reliable. Our unique technology combines 100% automated drone and image analysis algorithms to detect defects, lightning strikes, evaluate paint wear and check placards.
- Nepting — NEPTING is a company specializing in payment solutions and services with the main objective of supporting business in its evolution. Listening to its customers, it brings a skill, a culture, an innovative offer for all existing, emerging and future payment methods.NEPTING equips all types of points of acceptance with its multi-channel andmulti-vendor electronic payment system and its secure solutions in compliance with the standards in force. It is distinguished by its ability to give its customers the many advantages of a single and homogeneous offer for all its sales channels: mPOS, Retail, TPE, Automate, e-commerce ...
- ThIA Santé Mentale —
WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Pre-Seed
- Geography: United States, France, Denmark
Investor stats
- Total investments: 22
- Round size: Seed $3.4M–$20M; Series A $6.8M–$48M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
- uFraction8 — Multi-award-winning, innovative, microfluidics-based filter systems to provide bio-manufacturers with energy-efficient & ultra-scalable bioprocessing systems.
- Switch Bioworks — Switch Bioworks engineers symbiotic microbes to produce sustainable nitrogen fertilizer under the control of precise genetic circuits.
Wendel Growth is an investment arm of Wendel.
Show more...Investment focus
- Industry: Analytics, Open Source, Biotechnology
- Stage:Series A, Venture - Series Unknown
- Geography: France, Luxembourg
Investor stats
- Total investments: 6
- Round size: Series A $33M–$38M; Venture - Series Unknown $16M–$16M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- AQEMIA — Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.
- TaDaweb — Tadaweb is the first small data platform to scale Open Source intelligence for discovering and analysing information on the Internet.
Eutopia is a fund for consumer startups. We back founders who are rethinking the way we eat, shop, sleep and feel. We are backing 26 startups
Show more...Investment focus
- Industry: E-Commerce, Retail, Food and Beverage
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, Belgium, Denmark
Investor stats
- Total investments: 16
- Round size: Seed $2.4M–$10M; Series A $4M–$48M; Venture - Series Unknown $1.3M–$9.4M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $45M in 2019
Portfolio highlights
- Bastille — Bastille is a brand of urban bicycles. The Astir brand is synonymous with folding bicycles. The primary quality constraint Bastille, a British designer, aims to create a folding motorcycle with standard wheels rather than the mini 16-inch wheels that are traditionally associated with folding bikes.
- Moderato — Moderato is a retail and wholesale company that manufactures and supplies a range of beverages online to various sectors.
- SPRiNG Collective — SPRiNG is a consumer goods company that offers clean and efficient laundry and cleaning products, delivered in a 100% plastic-free box and directly in the mailbox. The company is headquartered in Paris, Ile-de-France, France by Philippe Cantet, Laure Favre, and Ben Guerville in 2017.
Point Nine Capital is a Berlin-based venture capital firm focused exclusively on early-stage Internet investments in areas like Software-as-a-Service (SaaS), online marketplaces, and mobile.The fund and its managers, Pawel Chudzinski and Christoph Janz have backed a number of highly successful Internet companies such as Delivery Hero, Clio,Shiftplanning, Vend, Typeform, and Zendesk from their earliest stages.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, France
Investor stats
- Total investments: 309
- Round size: Seed $900k–$7.5M; Series A $3.2M–$24M; Series B $9M–$62M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $173M in 2022
Portfolio highlights
- Kaiko — Kaiko provides real-time and historical cryptocurrency trade data, order books, and aggregated prices through a cryptocurrency API, downloadable CSV files, and a livestream WebSocket. We cover 100+ crypto exchanges and 35,000+ trading pairs for Bitcoin, Ethereum, and altcoins.
- Delivery Hero — Delivery Hero is the world's leading local delivery company. We are on a mission to deliver an amazing experience - fast, easy, and to your door.
- Polar Analytics — Your Shopify Analytics. Effortless. Centralized. Smart. Connect your datasource in one clic, automatically calculate KPIs. Visualize them all in one place. Get alerts and recommendations in realtime
Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Private Equity, Series A
- Geography: France, United States, Italy
Investor stats
- Total investments: 129
- Round size: Series A $1.5M–$11M; Private Equity $1.7M–$27M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely still investing — raised $452M in 2022
Portfolio highlights
- Cofarco — Official COFARCO twitter account. Commodity finance and trade credit insurance specialist.
- DESTIA Group — DESTIA Group is a provider of personal services to different aged people.
- Ekoscan Integrity — Ekoscan Integrity is an innovative solution for the integrity and sustainability of industrial products through the implementation of innovative technology.
SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series B, Series A
- Geography: France, United States, Germany
Investor stats
- Total investments: 47
- Lead/follow: no public data
Portfolio highlights
- Augure — Improve your brand performance with Launchmetrics' leading software solutions for fashion, lifestyle and beauty brands
- Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
- METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.
Noshaq offers financial services to help businesses develop.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed
- Geography: Belgium, France, Germany
Investor stats
- Total investments: 75
- Lead/follow: no public data
Portfolio highlights
- TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
- Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
- Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
Banque Populaire Group provides banking and credit services for individuals, international and corporate.
Show more...Investment focus
- Industry: Manufacturing, Energy, Software
- Stage:Seed, Pre-Seed
- Geography: France
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- ATAWEY — Founded in 2012 by Jean-Michel Amaré and Pierre-Jean Bonnefond, ATAWEY designs and manufactures turnkey autonomous energy solutions for isolated sites. The entrepreneurs and their teams use mature, tried and tested French technologies to offer you an innovative, reliable and sustainable product. They build on their expertise to give you more than asimple response: a solution that adapts to your uses.The teams are well aware of the importance and the challenges of a source of energy on isolated sites, ATAWEY guarantees you support and a tailor-made service. They take full responsibility for the management of each project for optimal adaptability and reliability, economic relevance with a fast return on investment, all with the greatest respect for the environment.
- Quotelo — Quotelo creates an automatization system for hoteliers to regain commercial independence in the hospitality industry and digitizes group-event-seminar reservations. The company's platform centralizes all requests and reservations for groups, events, and seminars for any type of establishment by adding a graphical chatbot to each hotel'swebsite and collecting MICE and group requests from customers automatically generating commercial proposals and reserving the rooms, restaurants, activities, and nights requested, allowing hotels to book seminars, meetings, or even events online and improve productivity, responsiveness, image, and predictability.
- Meccellis Biotech — Meccellis Biotech is a company specializing in acellular dermal matrices and tissue engineering, developing medical devices in La Rochelle.
Life Science Investor funding in France at a glance
Stats across 252 deals from 337 investors.
Access all 337 investors in France Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 337 investors investing in France Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!